Clinical summary
Summary
Eligible participants will receive liver radiation therapy called Stereotactic Ablative Body Radiotherapy (SABR). Kilovoltage Intrafraction Monitoring (KIM) tracking will be tested during mock treatment. If it is found to be successful, it will be used throughout treatment. If it is found to be unsuccessful, cone beam CT imaging will be used instead.Treatment Type
Radiotherapy,Systemic therapy (chemotherapy, hormone therapy or immunotherapy)Age
18 - 85
More information
Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Commercial Sponsor
University of Sydney
Scientific Title
LARK: Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)